The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors

Acta Radiologica

Volumn 55, Issue 2, 2014, Pages 140-148

  Jang, Kyung Mi ^a   Kim, Seong Hyun ^a   Lee, Soon Jin ^a   Choi, Dongil ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Magnetic resonance imaging; Neuroendocrine tumor; Pancreas

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; BENIGN AND MALIGNANT TUMORS; DIFFUSION WEIGHTED IMAGING; DIFFUSION-WEIGHTED MRI; NEUROENDOCRINE TUMORS; PANCREAS; PANCREATIC NEUROENDOCRINE TUMORS; QUALITATIVE AND QUANTITATIVE ANALYSIS;

DIFFUSION; FORECASTING; GRADING; TUMORS;

MAGNETIC RESONANCE IMAGING;

GADOXETIC ACID;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER SURGERY; CELL SHAPE; CLINICAL ARTICLE; CONSENSUS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; PANCREAS PRESERVING RESECTION; PANCREAS RESECTION; PANCREATIC NEUROENDOCRINE TUMOR; PANCREATICODUODENECTOMY; PICTURE ARCHIVING AND COMMUNICATION SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; YOUNG ADULT;

MAGNETIC RESONANCE IMAGING; NEUROENDOCRINE TUMOR; PANCREAS;

ADOLESCENT; ADULT; AGED; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84896753681     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185113494982     Document Type: Article

References (24)

1. Burns WR, Edil BH. Neuroendocrine pancreatic tumors: guidelines for management and update. Curr Treat Options Oncol 2012;13: 24-34.
2. Milan SA, Yeo CJ. Neuroendocrine tumors of the pancreas. Curr Opin Oncol 2012;24: 46-55.
3. DiNorcia J, Lee MK, Reavey PL, et al. One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques. J Gastrointest Surg 2010;14: 1536-1546.
4. Falconi M, Zerbi A, Crippa S, et al. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol 2010;17: 1621-1627.
5. Casadei R, Ricci C, Rega D, et al. Pancreatic endocrine tumors less than 4 cm in diameter: resector enucleate? a single-center experience. Pancreas 2010;39: 825-828.
6. Hackert T, Hinz U, Fritz S, et al. Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg 2011;396: 1197-1203.
7. Bettini R, Partelli S, Boninsegna L, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 2011;150: 75-82.
8. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009;40: 30-40.
9. Ferrone CR, Tang LH, Tomlinson J, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol 2007;25: 5609-5615.
10. Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003;125: 1094-1104.
11. d'Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors:tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009;250: 407-416.
12. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254: 47-66.
13. Padhani AR, Liu G, Koh DM, et al. Diffusionweighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11: 102-125.
14. Perman WH, Balci NC, Akduman I, Kuntz E. Magnetic resonance measurement of diffusion in the abdomen. Top Magn Reson Imaging 2009;20: 99-104.
15. Wang Y, Chen ZE, Yaghmai V, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 2011;33: 1071-1079.
16. Casadei R, Ricci C, Pezzilli R, et al. Are there prognostic factors related to recurrence in pancreatic endocrine tumors? Pancreatology 2010;10: 33-38.
17. Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010;39: 707-712.
18. Falconi M, Plockinger U, Kwekkeboom DJ, et al. Consensus Conference; European Neuroendocrine Tumor Society. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 2006;84: 196-211.
19. Parekh JR, Wang SC, Bergsland EK, et al. Lymph Node Sampling Rates and Predictors of Nodal Metastasis in Pancreatic Neuroendocrine Tumor Resections: The UCSF Experience With 149 Patients. Pancreas 2012;41: 840-844.
20. Pape UF, Jann H, Müller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 2008;113: 256-265.
21. Solorzano CC, Lee JE, Pisters PW, et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 2001;130: 1078-1085.
22. Herwick S, Miller FH, Keppke AL. MRI of islet cell tumors of the pancreas. Am J Roentgenol 2006;187:W472-W480.
23. Muraoka N, Uematsu H, Kimura H, et al. Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging 2008;27: 1302-1308.
24. Jang KM, Kim SH, Kim YK, et al. Imaging features of small (-3 cm) pancreatic solid tumors on gadoxeticacid- enhanced MR imaging and diffusion-weighted imaging: an initial experience. Magn Reson Imaging 2012;30: 916-925.